Differences between acute‐onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients

2018 ◽  
Vol 23 (3) ◽  
pp. 154-158 ◽  
Author(s):  
Lucas Alessandro ◽  
José M. Pastor Rueda ◽  
Miguel Wilken ◽  
Luis Querol ◽  
Mariano Marrodán ◽  
...  
Keyword(s):  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Acute Onset ◽  
Demyelinating Polyneuropathy ◽  
Adult Patients ◽  
Acute Inflammatory Demyelinating Polyneuropathy ◽  
Inflammatory Demyelinating Polyneuropathy

The Application of Clinical, Electrophysiological and Nerve Ultrasound Parameters in Distinguishing Acute-onset Chronic from Acute Inflammatory Demyelinating Polyneuropathy

2015 ◽  
Vol 10 (01) ◽  
pp. 85 ◽  
Author(s):  
Antonios Kerasnoudis ◽  
Kallia Pitarokoili ◽  
Ralf Gold ◽  
Min-Suk Yoon ◽  
◽  
...  
Keyword(s):  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Acute Onset ◽  
Demyelinating Polyneuropathy ◽  
Nerve Ultrasound ◽  
Diagnostic Challenge ◽  
Early Application ◽  
Immune Mediated ◽  
Inflammatory Demyelinating Polyneuropathy ◽  
Ultrasound Parameters

History-taking and nerve conduction studies are fundamental for the diagnosis and assessment of the severity of acute (AIDP) or chronic inflammatory demyelinating polyneuropathy (CIDP). The diagnostic challenge of distinguishing these two immune-mediated subacute polyradiculoneuropathies remains high, as intravenous immunoglobulin and steroids exert short-term clinical improvement in the majority of the CIDP cases, whereas steroids have no effect on AIDP patients. Accordingly, the precise classification of subacute polyradiculoneuropathies significantly affects the early application of steroids in CIDP. This review aims to give a timely update on the application of clinical, electrophysiological and nerve ultrasound parameters in distinguishing subacute CIDP from AIDP.

scholarly journals Reply: Biomarkers of ‘acute-onset’ chronic inflammatory demyelinating polyneuropathy

Brain ◽  
2014 ◽  
Vol 138 (3) ◽  
pp. e336-e336
Author(s):  
Susanna B. Park ◽  
Jia-Ying Sung ◽  
Jowy Tani ◽  
Matthew C. Kiernan ◽  
Cindy S.-Y. Lin
Keyword(s):  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Acute Onset ◽  
Demyelinating Polyneuropathy ◽  
Inflammatory Demyelinating Polyneuropathy

scholarly journals Dermatomyositis in the practice of a neurologist of the department of emergency neurology

2017 ◽  
Vol 98 (2) ◽  
pp. 267-271
Author(s):  
T V Matveeva ◽  
K E Egorova ◽  
R F Mullayanova
Keyword(s):  
Clinical Picture ◽  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Smooth Muscles ◽  
Connective Tissue Diseases ◽  
Skin Lesions ◽  
Demyelinating Polyneuropathy ◽  
Disease Course ◽  
Acute Inflammatory Demyelinating Polyneuropathy ◽  
Inflammatory Demyelinating Polyneuropathy ◽  
Emergency Neurology

Dermatomyositis is a disease from the group of diffuse connective tissue diseases mainly affecting the cross-striated and smooth muscles. The leading disorders in the clinical picture of dermatomyositis are movement disorders, which are often regarded to as a manifestation of acute inflammatory demyelinating polyneuropathy. Also skin lesions in the form of erythema and edema are characteristic, in the absence of these manifestations the term «polymyositis» is used. The disease proceeds with the development of severe neurological symptoms, and is dangerous because of complications which can lead to patient’s death. The article contains a description of cases of two female patients with the initial diagnosis of «Guillain-Barre syndrome». The analysis of the clinical picture, paraclinical studies, features of the disease course in patients was performed, and it enables differential diagnosis between acute/chronic inflammatory demyelinating polyneuropathy and dermatomyositiss at early stages of the disease.

scholarly journals Clinical case: criteria for differential diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy

2015 ◽  
pp. 48-52
Author(s):  
N.O. Kravchuk
Keyword(s):  
Peripheral Nerves ◽  
Progressive Disease ◽  
Age Of Onset ◽  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Demyelinating Polyneuropathy ◽  
Age Group ◽  
Nerve Roots ◽  
Acute Inflammatory Demyelinating Polyneuropathy ◽  
Sensory Disorders ◽  
Inflammatory Demyelinating Polyneuropathy

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disease that is characterized by inflammation of nerve roots and peripheral nerves, nerve destruction of the myelin sheath, the appearance of slowly-progressive symmetric symptoms, motor and sensory disorders. CIDPsometimes considered a chronic form of acute inflammatory demyelinating polyneuropathy (АIDP) - Guillain Barré syndrome (GBS). In contrast to GBS, most patients do not mark HDPNP previous viral or infectious disease. CIDP is subacute-progressive disease that clinically takes 3-4 weeks, then usually comes plateau phase, which changes the phase of gradual regression of symptoms. CIDP can affect any age group. CIDP registered twice as often in men. The average age of onset of the disease is 50 years. CIDP prevalence is estimated at about 5-7 cases per 100 thousand people.    

Sign in / Sign up

Export Citation Format

Share Document